From December 13, 2023 to December 31, 2023, the company has repurchased 111,600 shares, representing 0.01% for CNY 1.85 million. With this, the company has completed the repurchase of 111,600 shares, representing 0.01% for CNY 1.85 million under the buyback announced on December 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.88 CNY | -0.24% | +2.74% | -0.76% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.76% | 2.59B | |
+43.96% | 6.34B | |
-15.56% | 4.51B | |
-6.52% | 3.29B | |
+5.47% | 3.2B | |
+56.34% | 2.09B | |
-4.11% | 1.76B | |
+2.93% | 1.7B | |
-8.02% | 1.62B | |
+49.62% | 1.55B |
- Stock Market
- Equities
- 603858 Stock
- News Shandong Buchang Pharmaceuticals Co., Ltd.
- Tranche Update on Shandong Buchang Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 14, 2023.